7-16216097-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001101426.4(CRPPA):ā€‹c.1220T>Cā€‹(p.Leu407Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,601,278 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0020 ( 3 hom., cov: 33)
Exomes š‘“: 0.0010 ( 29 hom. )

Consequence

CRPPA
NM_001101426.4 missense

Scores

1
7
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.10
Variant links:
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA-AS1 (HGNC:48962): (CRPPA antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009187013).
BP6
Variant 7-16216097-A-G is Benign according to our data. Variant chr7-16216097-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 129285.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00196 (299/152352) while in subpopulation EAS AF= 0.0285 (148/5188). AF 95% confidence interval is 0.0248. There are 3 homozygotes in gnomad4. There are 158 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CRPPANM_001101426.4 linkuse as main transcriptc.1220T>C p.Leu407Ser missense_variant 9/10 ENST00000407010.7 NP_001094896.1
CRPPA-AS1NR_038947.1 linkuse as main transcriptn.118+5494A>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CRPPAENST00000407010.7 linkuse as main transcriptc.1220T>C p.Leu407Ser missense_variant 9/105 NM_001101426.4 ENSP00000385478 P1A4D126-1
CRPPA-AS1ENST00000438573.5 linkuse as main transcriptn.116+5494A>G intron_variant, non_coding_transcript_variant 1

Frequencies

GnomAD3 genomes
AF:
0.00196
AC:
299
AN:
152234
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00316
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0285
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00234
AC:
569
AN:
242910
Hom.:
10
AF XY:
0.00224
AC XY:
295
AN XY:
131498
show subpopulations
Gnomad AFR exome
AF:
0.00273
Gnomad AMR exome
AF:
0.000120
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0273
Gnomad SAS exome
AF:
0.00134
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000899
Gnomad OTH exome
AF:
0.000846
GnomAD4 exome
AF:
0.00105
AC:
1519
AN:
1448926
Hom.:
29
Cov.:
27
AF XY:
0.00108
AC XY:
777
AN XY:
720808
show subpopulations
Gnomad4 AFR exome
AF:
0.00331
Gnomad4 AMR exome
AF:
0.0000924
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0300
Gnomad4 SAS exome
AF:
0.00131
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000905
Gnomad4 OTH exome
AF:
0.00169
GnomAD4 genome
AF:
0.00196
AC:
299
AN:
152352
Hom.:
3
Cov.:
33
AF XY:
0.00212
AC XY:
158
AN XY:
74506
show subpopulations
Gnomad4 AFR
AF:
0.00315
Gnomad4 AMR
AF:
0.000261
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0285
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00103
Hom.:
0
Bravo
AF:
0.00213
ESP6500AA
AF:
0.00279
AC:
10
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00223
AC:
269
Asia WGS
AF:
0.0100
AC:
35
AN:
3472
EpiCase
AF:
0.0000547
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Likely benign, criteria provided, single submitterclinical testingAthena DiagnosticsMar 15, 2017- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Oct 22, 2015- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 22, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
Congenital Muscular Dystrophy, alpha-dystroglycan related Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.063
T;.
Eigen
Benign
0.025
Eigen_PC
Benign
0.062
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.77
T;T
MetaRNN
Benign
0.0092
T;T
MetaSVM
Uncertain
0.0095
D
MutationAssessor
Uncertain
2.2
M;.
MutationTaster
Benign
0.98
D;D
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.7
N;N
REVEL
Uncertain
0.52
Sift
Uncertain
0.0010
D;D
Sift4G
Pathogenic
0.0010
D;D
Polyphen
0.94
P;.
Vest4
0.60
MVP
0.78
MPC
0.34
ClinPred
0.043
T
GERP RS
3.9
Varity_R
0.47
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141625803; hg19: chr7-16255722; COSMIC: COSV101235309; API